Merck Recalls Chemotherapy Drugs Due to Broken Caps
Merck, a popular prescription drug company, is recalling 276,000 bottles of chemotherapy drug due to a potential failure in the bottles’ child-proof caps.
Prescription Drug Bottle Defect Puts Children at Risk
According to the ABC News, Merck issued the recall after noting that cracks may have occurred in the child-proof caps during the manufacturing process. The cracked bottles could be accessible to young children, posing a serious health hazard.
Although Merck notes the cracks are likely for 1,000 bottles, the recall was issued for 276,000 bottles to reassure quality control.
The affected drug bottles were sold between July 2013 and August 2015. The specific name of the product is Temodar but could also be purchased as Temozolomide which is the generic version.
If you or someone you know is taking either of the two Merck products, it is important to inspect the product and call Merck for a replacement cap.
Accidental Drug Overdose Too Common Among Kids
The following information was provided by WebMD:
- An average of 60,000 young children are treated for overdoses that occurred from the child accessing medicines when their parents or guardians were not paying attention.
- Roughly one in every 150 2-year-olds is treated for unintential drug overdose each year.
- No package in 100% childproof, take additional measures to ensure your child’s safety:
- Place all medicines out of children’s reach.
- Never leave medicines on the counter, even for a minute.
- Never tell children that medicine is candy in order to get them to take it.
- In case of emergency, have the following number posted – POISON CONTROL: 1-800-222-1222.
RECENT MEDICAL MALPRACTICE RESULT
$10.9 MillionExpenses: $175,000.00 | Attorneys Fees: $3,200,000.00 | Net to Client: $4,029,762.00 (Purchase of a Lifetime Annuity)
RECENT VEHICLE RECALL RESULT
$30.2 MillionExpenses: $39,576.15 | Attorneys Fees: $10,060,980.00 | Net to Client: $20,121,960.57